BridgeMD
New treatment option for Chronic Stroke
Official title High Intensity Interval Training in Chronic Stroke
ClinicalTrials.gov ID: NCT06474832
What this study is testing
- What it's testing
- Both gait and cardiovascular dysfunction are primary factors limiting community ambulation for stroke individuals. Increased gait variability and asymmetry contributes to a higher risk of falls, leading to reduced physical activity, decreased cardiorespiratory endurance, and increased walking economy and sympathetic nervous system activity, thereby potentially triggering secondary strokes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 69
You may be able to join if
- Aged 18-69 years
- At least 6 months post-stroke
- Functional Ambulation Category (FAC) ≥ 3
- Mini-Mental State Examination (MMSE) ≥ 24
- Able to walk 10 meters overground with or without assistive devices
You likely can't join if
- Unstable cardiopulmonary conditions within the last 3 months
- Other chronic neurological disorders
- Contraindications to exercise as recommended by the American College of Sports Medicine (ACSM)
- Severe lower limb spasticity (Modified Ashworth Scale \> 2 points)
- Implanted pacemaker or cardioverter defibrillator
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.